prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
36061,1.40389110000e+16,93089020,44,Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd),Ranibizumab,10mg/1ml,Solution for injection,Intravitreal,Subfoveal Choroidal Neovascularisation,February 2009,15143001,,,,,,,,,0,11080252
32594,4811811000001106,77903020,0,Visudyne 15mg powder for solution for infusion vials (Cheplapharm Arzneimittel GmbH),Verteporfin,15mg,Powder for solution for infusion,Intravenous,Subfoveal Choroidal Neovascularisation,February 2009,8028001,,,,,,,,,0,11080252
38892,1.40576110000e+16,93075020,10,Ranibizumab 2.3mg/0.23ml solution for injection vials,Ranibizumab,10mg/1ml,Solution for injection,Intravitreal,Subfoveal Choroidal Neovascularisation,February 2009,15136001,,,,,,,,,0,11080252
61901,2.46075110000e+16,26956021,24,Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd),Ranibizumab,10mg/1ml,Solution for injection,Intravitreal,Subfoveal Choroidal Neovascularisation,January 2015,26956021,,,,,,,,,0,11080252
64184,2.46107110000e+16,26955021,3,Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes,Ranibizumab,10mg/1ml,Solution for injection,Intravitreal,Subfoveal Choroidal Neovascularisation,September 2015,26955021,,,,,,,,,0,11080252
37829,327048008,77752020,0,Verteporfin 15mg powder for solution for infusion vials,Verteporfin,15mg,Powder for solution for infusion,Intravenous,Subfoveal Choroidal Neovascularisation,February 2009,7977001,,,,,,,,,0,11080252
36309,1.03635110000e+16,90851020,1,Macugen 300micrograms/0.09ml solution for injection pre-filled syringes (Pfizer Ltd),Pegaptanib sodium,3.33mg/1ml,Solution for injection,Intravitreal,Subfoveal Choroidal Neovascularisation,February 2009,14018001,,,,,,,,,0,11080252
